Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CITALOPRAM HYDROBROMIDE

CITALOPRAM HYDROBROMIDE

Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 021763 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CITALOPRAM HYDROBROMIDE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - EQ 20MG BASE Sponsor BIOVAIL LABS INTL Submission history Latest submission status date: 2005-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 021763 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CITALOPRAM HYDROBROMIDE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - EQ 20MG BASE Sponsor BIOVAIL LABS INTL Submission history Latest submission status date: 2005-12-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.